Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.
Adults with autoimmune rheumatic conditions who developed COVID-19 and received booster or updated (2023-2024) COVID-19 vaccines were less likely to be hospitalized for COVID-19 compared to those who received only the initial series vaccines or who were unvaccinated.
Read storyA basin-wide study of 13 drinking water sources in China’s Poyang Lake region shows that water source type can strongly shape the occurrence and spread of antibiotics, antibiotic resistance genes, and resistant bacteria.
The risk of being hospitalised for flu or pneumonia can be reduced with a high-dose flu vaccine for older people with chronic lung disease, according to the combined results of two large clinical trials.
New research shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequent development of type 1 diabetes (T1D). Furthermore, the effect is evident only in people who did not receive the SARS-CoV-2 vaccine.
AMI’s Global Ambassador for the Americas, Dr. Filipa Godoy-Vitorino, Chair of the Department of Microbiology at the University of Puerto Rico, reveals why she is spearheading the planned Puerto Rico Center for Microbiome Sciences (PR-CMS)—the first of its kind in the region.
Dr Ni Luh Putu Harta Wedari, a medical doctor and Clinical Microbiology Specialist from Bali, Indonesia reveals how engaging with AMI has expanded her international network and unveiled new opportunities.
A new study has identified differences in the makeup and organization of the small bowel microbiome between women and men. One intriguing finding was a bacterial community containing Granulicatella, found only in women.
Researchers have identified biologically active compounds with antiviral, antimicrobial, and anti-inflammatory effects in several plant species native to Kazakhstan, providing new chemical and experimental data on medicinal flora from Central Asia.
Professor Romain Glèlè Kakaï believes combining traditional mathematical models with artificial intelligence will improve the accuracy of epidemic forecasting and help public health leaders respond more quickly to future cholera and malaria outbreaks.
The hospital-associated pathogen Pseudomonas aeruginosa has type VI secretion systems (T6SSs). Most reference strains encode three T6SSs, but comparative genomics has identified an additional H4-T6SS in a subset of clinical isolates.
Students heading into freshers’ week are being warned not to assume a headache, vomiting or feeling wiped out is simply the result of a heavy night or the dreaded “freshers’ flu”. 246,089 doses of the MenB vaccine were administered to young people in England between 20 July and 31 August.
Common bacteria found in classroom dust are associated with reduced lung function in children according to new research, Children in classrooms with higher levels of Streptomyces had a 0.08 litres lower forced vital capacity (FVC).
Scientists have identified an unexpected participant in androgen chemistry: a bacterium from the human urinary tract that can convert the steroid precursor DHEA into testosterone under laboratory conditions. It reveals a previously unknown microbial route to a hormone that is central to prostate biology.
Practically since its discovery, the highly contagious bacterium Clostridioides difficile has been reported to not cause symptoms in infants. But new findings suggest that the bacterium can reshape the developing infant gut and may have long-term consequences.
Researchers have identified what may potentially be a missing link between specific activities in gut bacteria and the liver disease primary sclerosing cholangitis: the metabolite ImP, a molecule formed when certain gut bacteria break down dietary components.
Researchers have developed a novel “mosaic” nanoparticle vaccine platform that successfully penetrates the mucus barrier to deliver broad-spectrum mucosal protection against a diverse array of coronaviruses, including highly evasive SARS-like and MERS-like strains.
The Gerontological Society of America (GSA) supports the 2026-27 respiratory season vaccine evidence review released by the Vaccine Integrity Project (VIP) in collaboration with the American Medical Association.
Researchers have developed an injectable MXene-based composite hydrogel (GQM) for the treatment of periodontitis. The hydrogel consists of oxidized gellan gum (OG), quaternized chitosan (QCS), and magnesium-tannic acid modified MXene nanosheets (MTA-Mg).
A new collaboration at ISM–RIKEN Targeting Microbiota 2026 will bring the Global Grants for Gut Health programme to Tokyo, alongside a dedicated funding discussion and three Best Abstract Prizes.
Researchers analyzed the various conformations that a chaperone protein adopts while delivering unfolded outer membrane proteins to the assembly machinery.
A new review of plant-based diets concludes that the body actively adapts to sustained dietary change, absorbing iron more efficiently, synthesizing more of its own creatine and carnosine, using protein more economically, and remodeling gut bacteria to better ferment fiber.
A critical aspect of managing pleural infection is understanding differences between hospital-acquired and community-acquired forms, as these two entities differ fundamentally in etiology, microbiology, antimicrobial resistance patterns, and patient populations.
A new study shows that phage therapy – the use of tiny viruses to kill bacteria without harming people – could help to reduce recurrent infections, which happen when the bacteria responsible for UTIs ‘hide’ in the tissue of the bladder.